These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28441497)

  • 1. Development of a Biorelevant, Material-Sparing Membrane Flux Test for Rapid Screening of Bioavailability-Enhancing Drug Product Formulations.
    Stewart AM; Grass ME; Mudie DM; Morgen MM; Friesen DT; Vodak DT
    Mol Pharm; 2017 Jun; 14(6):2032-2046. PubMed ID: 28441497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Drug-Rich Colloids of Itraconazole and HPMCAS on Membrane Flux in Vitro and Oral Bioavailability in Rats.
    Stewart AM; Grass ME; Brodeur TJ; Goodwin AK; Morgen MM; Friesen DT; Vodak DT
    Mol Pharm; 2017 Jul; 14(7):2437-2449. PubMed ID: 28591516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward Developing Discriminating Dissolution Methods for Formulations Containing Nanoparticulates in Solution: The Impact of Particle Drift and Drug Activity in Solution.
    Arce FA; Setiawan N; Campbell HR; Lu X; Nethercott MJ; Bummer P; Su Y; Marsac PJ
    Mol Pharm; 2020 Nov; 17(11):4125-4140. PubMed ID: 32965123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole.
    Kumar S; Shen J; Burgess DJ
    J Control Release; 2014 Oct; 192():95-102. PubMed ID: 25009979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
    Mou D; Chen H; Wan J; Xu H; Yang X
    Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Bioavailability Strategy for Decisions on Clinical Drug Formulation Development: An In Depth Analysis.
    Van den Bergh A; Van Hemelryck S; Bevernage J; Van Peer A; Brewster M; Mackie C; Mannaert E
    Mol Pharm; 2018 Jul; 15(7):2633-2645. PubMed ID: 29799758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical Approach to Modeling the Impact of Amorphous Drug Nanoparticles on the Oral Absorption of Poorly Soluble Drugs.
    Stewart AM; Grass ME
    Mol Pharm; 2020 Jan; 17(1):180-189. PubMed ID: 31743032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule.
    Thiry J; Kok MG; Collard L; Frère A; Krier F; Fillet M; Evrard B
    Eur J Pharm Sci; 2017 Mar; 99():1-8. PubMed ID: 27951411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations.
    Karashima M; Sano N; Yamamoto S; Arai Y; Yamamoto K; Amano N; Ikeda Y
    Eur J Pharm Biopharm; 2017 Jun; 115():65-72. PubMed ID: 28223260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2).
    Brough C; Miller DA; Ellenberger D; Lubda D; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):180-90. PubMed ID: 26863889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1).
    Brough C; Miller DA; Keen JM; Kucera SA; Lubda D; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):167-79. PubMed ID: 26637232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation.
    Yeap YY; Trevaskis NL; Quach T; Tso P; Charman WN; Porter CJ
    Mol Pharm; 2013 May; 10(5):1874-89. PubMed ID: 23480483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface Dissolution UV Imaging for Investigation of Dissolution of Poorly Soluble Drugs and Their Amorphous Formulation.
    Long CM; Tang K; Chokshi H; Fotaki N
    AAPS PharmSciTech; 2019 Feb; 20(3):113. PubMed ID: 30761437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs.
    Duhem N; Rolland J; Riva R; Guillet P; Schumers JM; Jérome C; Gohy JF; Préat V
    Int J Pharm; 2012 Feb; 423(2):452-60. PubMed ID: 22212463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryogenic liquids, nanoparticles, and microencapsulation.
    Purvis T; Vaughn JM; Rogers TL; Chen X; Overhoff KA; Sinswat P; Hu J; McConville JT; Johnston KP; Williams RO
    Int J Pharm; 2006 Oct; 324(1):43-50. PubMed ID: 16814968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.